CytoDyn Inc. (BST:296)

CytoDyn Statistics

Total Valuation

CytoDyn has a market cap or net worth of EUR 302.67 million. The enterprise value is 322.01 million.

Market Cap	302.67M
Enterprise Value	322.01M

Important Dates

The next estimated earnings date is Friday, April 10, 2026.

Earnings Date	Apr 10, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.28B
Shares Outstanding	n/a
Shares Change (YoY)	+14.45%
Shares Change (QoQ)	+0.68%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	0.03%
Float	1.28B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-2.93
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.25
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.10

Current Ratio	0.10
Quick Ratio	0.06
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.30

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-70.67%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	25.09%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-2.68M
Employee Count	13
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	0.22
200-Day Moving Average	n/a
Relative Strength Index (RSI)	51.78
Average Volume (20 Days)	7,542

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	20.28

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-16.48M
Pretax Income	-33.51M
Net Income	-34.79M
EBITDA	-16.47M
EBIT	-16.48M
Earnings Per Share (EPS)	-0.03

Balance Sheet

The company has 4.30 million in cash and 23.52 million in debt, with a net cash position of -19.22 million.

Cash & Cash Equivalents	4.30M
Total Debt	23.52M
Net Cash	-19.22M
Net Cash Per Share	n/a
Equity (Book Value)	-103.27M
Book Value Per Share	-0.08
Working Capital	-65.78M

Cash Flow

Operating Cash Flow	-15.02M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CytoDyn does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.45%
Shareholder Yield	-14.45%
Earnings Yield	-11.50%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1